Login

Bal Pharma Ltd.

₹106.56

Overview Charts Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Corp. Action Documents
Consolidated
Standalone

Bal Pharma Ltd.

  • NSE : BALPHARMA

₹106.56

₹106.56

-0.03 (-0.03%) - 12 Jun 2025 04:11 PM
  • NSE : BALPHARMA

About Company

Bal Pharma Limited is a leading Indian Pharmaceutical Company specializing in Prescription Drugs, Branded Formulations, APIs, Generic & OTC products, Intravenous Infusions and Bulk Drugs. It has a rich experience of 25 years in the International and Domestic operations. The company has 5 state of the art manufacturing facilities located pan India. The plants are approved by major International Regulatory Authorities like WHO-GMP, ISO 9001-2008. It has DMF approvals for Ebastine and Gliclazide in Japan and European markets. DMF filed for Bepotastine in US FDA. The company is adequately backed with in-house R&D, Clinical Research, Regulatory and other back end capabilities.

Market Cap. ₹ 158 Cr.
52 Week - High/Low ₹ 158/89
P/E Ratio 16.00
P/B Ratio 1.48
Enterprise Value ₹ 195 Cr.
ROE % 10.3
RSI Value 51.03
EMA 50 99.46
EMA 200 107.17
Market Cap. ₹ 158 Cr.
52 Week - High/Low ₹ 158/89
P/E Ratio 21.66
P/B Ratio 2.25
Enterprise Value ₹ 193 Cr.
ROE % 11.19
RSI Value 51.03
EMA 50 99.46
EMA 200 107.17
Add Parameters

Growth

Valuation

Calculators

Peer Comparison

Industry - Pharmaceuticals & Drugs

* Please refer to the Standalone data if Consolidated financial data for the company is not available.

Shareholding Pattern Numbers in percentages

Insight market
Terms | Privacy | Contact Us
Copyright © 2025 All rights reserved with INVESMATE INSIGHTS PRIVATE LIMITED | All logos and Trademarks registered with their respective owners.